CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-30 | Evans John M. CEO | Option exercise 10b5-1 | +30,000 | $0.67 | $20K | 968,659 |
| 2025-01-30 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 69,336 | ||
| 2025-01-30 | Evans John M. CEO | Sale 10b5-1 | −29,800 | $26.75 | $797K | 908,859 |
| 2025-01-30 | Evans John M. CEO | Sale 10b5-1 | −200 | $27.28 | $5K | 908,659 |
| 2025-01-02 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,241 | $24.68 | $31K | 102,968 |
| 2025-01-02 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −1,117 | $24.68 | $28K | 43,814 |
| 2024-12-31 | Emany Sravan Kumar Chief Financial Officer | Grant or award | +80,000 | 80,000 | ||
| 2024-12-31 | Emany Sravan Kumar Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-12-17 | Ciaramella Giuseppe President | Option exercise | +53,500 | $0.67 | $36K | 162,650 |
| 2024-12-17 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) | −53,500 | 6,505 | ||
| 2024-12-02 | Guindo Chirfi Director | Grant or award · Stock Option (Right to Buy) | +39,086 | 39,086 | ||
| 2024-11-06 | Ciaramella Giuseppe President | Sale 10b5-1 | −51,110 | $26.36 | $1.3M | 109,150 |
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise 10b5-1 | +27,318 | $0.67 | $18K | 196,934 |
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise 10b5-1 | +12,979 | $4.22 | $55K | 209,913 |
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise 10b5-1 | +1,457 | $7.22 | $11K | 211,370 |
| 2024-10-14 | Ciaramella Giuseppe President | Sale 10b5-1 | −51,110 | $26.27 | $1.3M | 160,260 |
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,318 | 0 | ||
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,979 | 0 | ||
| 2024-10-14 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,457 | 0 | ||
| 2024-10-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −385 | $23.48 | $9K | 104,209 |
Page 7 of 32 · 630 trades